Recruiting Pneumonia Studies in Los Angeles
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental oxygen, on the prevention of death or progression t...
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants
The objective of the study is to evaluate the safety, tolerability, and immunogenicity of 4 injections of VAX-31 (at 4 dose levels) compared to PCV20 in infants at 2, 4, 6, and 12-15 months of age, in...
About Pneumonia Clinical Trials in Los Angeles
Pneumonia is an infection that inflames the air sacs in one or both lungs, which may fill with fluid or pus. It can range from mild to life-threatening. Treatment depends on the cause and severity, including antibiotics, antivirals, and supportive care.
There are currently 2 pneumonia clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 3,770 participants. Research is being sponsored by AstraZeneca, Vaxcyte, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pneumonia Clinical Trials in Los Angeles — FAQ
Are there pneumonia clinical trials in Los Angeles?
Yes, there are 2 pneumonia clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Los Angeles?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.
Are clinical trials in Los Angeles free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.
What pneumonia treatments are being tested?
The 2 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for pneumonia.
Data updated March 2, 2026 from ClinicalTrials.gov